Bio-Rad Labs (BIO) Income Statement

Click line-items for a historical chart and %

Net sales	516.78M
Cost of goods sold	236.55M
Gross profit	280.23M
Selling, general and administrative expense	205.54M
Research and development expense	52.17M
Income from operations	22.53M
Interest expense	5.63M
Foreign exchange losses, net	1.24M
Other (income) expense, net	-11.21M
Income before income taxes	26.86M
Provision for income taxes	-8.85M
Net income including noncontrolling interests	0
Net loss (income) attributable to noncontrolling interests
Net income attributable to Bio-Rad	18.01M
Net income per share basic attributable to Bio-Rad	0.61
Weighted average common shares - basic	29.4M
Net income per share diluted attributable to Bio-Rad	0.61
Weighted average common shares - diluted	29.59M

Entities mentioned with BIO

View All Entities